Copsac’s mission is to improve prevention of chronic inflammatory diseases, diagnosis and treatment of childhood asthma. It is our goal to be an international centre of excellence.
Translational clinical research approach based on long-term studies of mother-child cohorts with deep phenotyping and exposure assessment
Description of COPSAC methods
Media and press releases
Complete list of COPSAC’s peer-reviewed papers
Latest news about COPSAC in the press
The COPSAC study with its translational clinical research approach based on long-term studies of mother-child cohorts with deep phenotyping and exposure assessment, combined with genotyping and sequencing of the microbiome, insight into the genetic regulation of basic biological processes, and state-of-the-art systems biology methods holds the promise to improve our understanding of the processes causing disease in individual patients and the interaction between heredity and environment.
Cat exposure in early life decreases asthma risk from the 17q21 high-risk variant
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring.
Precision allergy: Separate allergies to male and female dogs